Effect of vessel diameter on the clinical benefits of drug-coated balloon angioplasty: Insights from paclitaxel-coated balloon and polymer-free sirolimus-eluting stent studies
In this real-world experience PCB and PF-SES angioplasty were associated with low clinical event rates. There was no difference in clinical efficacy between PCB and PF-SES in large and small vessel PCI in terms of clinically driven TLR and MACE. Previously reported higher rates for clinical events after DCB angioplasty in large coronary vessels ≥ 3 mm could not be observed.
Authors
- Matthias Waliszewski (ORCID: https://orcid.org/0000-0002-8689-4505)
- Klaus Bonaventura (ORCID: https://orcid.org/0000-0001-9581-4637)
- Mark Rosenberg (ORCID: https://orcid.org/0000-0002-6773-6739)
- Uwe Zeymer (ORCID: https://orcid.org/0000-0001-7077-283X)
- Quentin Landolff (ORCID: https://orcid.org/0000-0003-4022-2065)
- Monica Verdoia (ORCID: https://orcid.org/0009-0001-7192-7079)
- Florian Krackhardt
- Rene Koning
Institutions
- University of Freiburg (DE)
- Ospedale degli Infermi (IT)
- Klinikum Aschaffenburg (DE)
- Kraftanlagen (Germany) (DE)
- Stiftung Institut für Herzinfarktforschung (DE)
- Universitäts-Herzzentrum Freiburg-Bad Krozingen (DE)
- B. Braun (Germany) (DE)
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
- Klinikum Ernst von Bergmann (DE)
Publication Details
- Journal
- Clinical Research in Cardiology
- Published
- 2026-01-08
- DOI
- https://doi.org/10.1007/s00392-025-02819-w
- Primary Topic
- Coronary Interventions and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00